THC-Related QT Prolongation in Dogs Needed Heart-Rate Correction for Interpretation

Longer uncorrected QT intervals in the canine cannabis study did not by themselves establish equivalent prolongation after accounting for heart rate. The paper evaluated corrected intervals as a separate measure.

The study measured several cardiac intervals

Six male Beagles received THC, CBD and combination oils in a crossover design. THC prolonged uncorrected QT intervals at selected cumulative doses. The investigators also calculated a heart-rate-corrected QT using Van de Water’s formula rather than treating the uncorrected interval as the only cardiac endpoint.

Correction addresses a different interpretive question

QT duration varies with cardiac timing, so a change alongside altered RR intervals requires context. The authors discussed corrected QT values remaining within their referenced normal range. That observation is narrower than saying THC produced no cardiac effects, because other interval changes were present.

A biomarker is not an observed clinical event

Neither an altered interval nor a corrected value within a reference range establishes the incidence of dangerous arrhythmias. Six healthy male dogs under acute monitored conditions cannot characterize rare events or every clinical population. The separate T-wave measures also did not show significant changes in the tested comparisons. These findings concern veterinary physiology and do not supply a human THC blood threshold. The useful distinction is to report the raw interval, the correction method and the clinical observations separately before drawing a cardiac-risk conclusion.

Related analysis: the canine study’s separate physiological outcomes.

Research cited

Rutjanavate, Dong and Sawangkoon. Cumulative Effects of Cannabis Oils on Body Temperature, Electrocardiography, Heart Rate Variability, Blood Pressure, and Respiratory Function in Telemetered Dogs. DOI: 10.4103/IJVSM.IJVSM_3_25.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Rheumatoid-Arthritis Cannabis-Spray Trial Measured Pain Relief Rather Than Joint Protection

A small rheumatoid-arthritis trial summarized in a nabiximols review found improvement in selected pain outcomes. Those symptom findings did not establish that the spray prevented joint damage or replaced disease-modifying treatment. The trial tested a standardized combination The placebo-controlled study involved 58 patients treated for five weeks with THC:CBD oromucosal…

Spread the love

Read Article: A Rheumatoid-Arthritis Cannabis-Spray Trial Measured Pain Relief Rather Than Joint Protection

Responder Findings in a Small Nabiximols Chemotherapy-Pain Pilot Remained Exploratory

A small crossover pilot of nabiximols for chemotherapy-induced neuropathic pain did not show a significant average treatment effect, although a responder analysis identified some patients with meaningful relief. That pattern supports a research lead rather than a validated way to select responders. The average comparison was not positive The review’s…

Spread the love

Read Article: Responder Findings in a Small Nabiximols Chemotherapy-Pain Pilot Remained Exploratory

A Nabiximols Spinal-Cord-Injury Trial Found Similar Pain Changes With Spray and Placebo

A trial of THC:CBD spray for spinal-cord-injury neuropathic pain reported nearly identical average pain changes with active treatment and placebo. Improvement from baseline alone did not demonstrate an added spray benefit. The comparison concerned a defined pain population The review summarizes a randomized study registered as NCT01606202. Its evidence table…

Spread the love

Read Article: A Nabiximols Spinal-Cord-Injury Trial Found Similar Pain Changes With Spray and Placebo

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us